Skip to main content
Log in

Varicella zoster virus vaccine worth it in older adults?

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Rothberg MB, Virapongse A, Smith KJ.Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Clinical Infectious Diseases 44: 1280-1288, No. 10, 15 May 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Varicella zoster virus vaccine worth it in older adults?. Pharmacoecon. Outcomes News 529, 7 (2007). https://doi.org/10.2165/00151234-200705290-00018

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705290-00018

Keywords

Navigation